References
Original article
Puri, R. et al. Effect of C-reactive protein on lipoprotein(a)-associated cardiovascular risk in optimally treated patients with high-risk vascular disease: a prespecified secondary analysis of the ACCELERATE trial. JAMA Cardiol. https://doi.org/10.1001/jamacardio.2020.2413 (2020)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Huynh, K. Targeting Lp(a) to reduce ASCVD risk. Nat Rev Cardiol 17, 612 (2020). https://doi.org/10.1038/s41569-020-0425-5
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41569-020-0425-5
- Springer Nature Limited